Directory
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Degree: PhD

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publications

  • Bermúdez-López, Marcelino; Martínez-Alonso, Montse; Castro-Boqué, Eva; Betriu, Àngels; Cambray, Serafí; Farràs, Cristina; Barbé, Ferran; Pamplona, Reinald; Lecube, Albert; Mauricio, Dídac; Purroy, Francisco; Valdivielso, José Manuel; Fernández, Elvira

    Localización y carga de ateromatosis subclínica en población con un riesgo cardiovascular bajo-moderado: estudio ILERVAS

    REVISTA ESPANOLA DE CARDIOLOGIA 74 1043-1054. .

    [doi:10.1016/j.recesp.2020.09.024]

  • Cambray S; Bermudez-Lopez M; Bozic M; Valdivielso JM; NEFRONA investigators

    Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease.

    CLINICAL KIDNEY JOURNAL 13 1017-1024. .

    [doi:10.1093/ckj/sfaa014]

  • Bermudez-Lopez, M; Forne, C; Cambray, S; Bozic, M; Valdivielso, JM

    OUTCOMES AND HEALTHCARE RESOURCES UTILIZATION DIFFERENCES IN PATIENTS WITH AND WITHOUT SECONDARY HYPERPARATHYROIDISM FROM THE NEFRONA COHORT

    VALUE IN HEALTH 23 753-753. .

  • Marchant, V; Tejera-Munoz, A; Marquez-Exposito, L; Rayego-Mateos, S; Rodrigues-Diez, RR; Tejedor, L; Santos-Sanchez, L; Egido, J; Ortiz, A; Valdivielso, JM; Fraser, DJ; Lopez-Cabrera, M; Selgas, R; Ruiz-Ortega, M

    IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.

    Biomolecules 10 1-36. .

    [doi:10.3390/biom10101361]

  • Sumida K; Nadkarni GN; Grams ME; Sang Y; Ballew SH; Coresh J; Matsushita K; Surapaneni A; Brunskill N; Chadban SJ; Chang AR; Cirillo M; Daratha KB; Gansevoort RT; Garg AX; Iacoviello L; Kayama T; Konta T; Kovesdy CP; Lash J; Lee BJ; Major RW; Metzger M; Miura K; Naimark DMJ; Nelson RG; Sawhney S; Stempniewicz N; Tang M; Townsend RR; Traynor JP; Valdivielso JM; Wetzels J; Polkinghorne KR; Heerspink HJL

    Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis.

    ANNALS OF INTERNAL MEDICINE 173 426-435. .

    [doi:10.7326/M20-0529]

  • Rayego-Mateos S; Morgado-Pascual JL; Valdivielso JM; Sanz AB; Bosch-Panadero E; Rodrigues-Díez RR; Egido J; Ortiz A; González-Parra E; Ruiz-Ortega M

    TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease.

    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 31 2026-2042. .

    [doi:10.1681/ASN.2019111206]

  • Cambray S; Ibarz M; Bermudez-Lopez M; Marti-Antonio M; Bozic M; Fernandez E; Valdivielso JM

    Magnesium Levels Modify the Effect of Lipid Parameters on Carotid Intima Media Thickness.

    Nutrients 12 1-12. .

    [doi:10.3390/nu12092631]

  • Valdivielso, JM; Eritja À; Caus, M; Bozic, M

    Glutamate-Gated NMDA Receptors: Insights into the Function and Signaling in the Kidney.

    Biomolecules 10 1-18. .

    [doi:10.3390/biom10071051]

  • Rayego-Mateos, S; Valdivielso, JM

    New therapeutic targets in chronic kidney disease progression and renal fibrosis.

    Expert Opinion On Therapeutic Targets 24 655-670. .

    [doi:10.1080/14728222.2020.1762173]

  • Dolade, N; Rayego-Mateos, S; Garcia-Carrasco, A; Perez-Gomez, A; Crespo-Masip, M; Guerin, M; Tharaux, PL; Valdivielso, JM

    EPIGENETIC REGULATION OF CHRONIC KIDNEY DISEASE ACCELERATED-ATHEROSCLEROSIS

    NEPHROLOGY DIALYSIS TRANSPLANTATION 35 1041-1041. .

  • Castro-Alonso, C; D'Marco, L; Pomes, J; Del Amo Conill M; Garcia-Diez, AI; Molina, P; Puchades, MJ; Valdivielso, JM; Escudero, V; Bover, J; Navarro-Gonzalez, J; Ribas, B; Pallardo, LM; Gorriz, JL

    Prevalence of Vertebral Fractures and Their Prognostic Significance in the Survival in Patients with Chronic Kidney Disease Stages 3?5 Not on Dialysis.

    Journal of Clinical Medicine 9 1-11. .

    [doi:10.3390/jcm9051604]

  • Martinez-Lopez, D; Roldan-Montero, R; Garcia-Marques, F; Nuñez E; Jorge, I; Camafeita, E; Minguez, P; Rodriguez de Cordoba S; Lopez-Melgar, B; Lara-Pezzi, E; Fernandez-Ortiz, A; Ibáñez B; Valdivielso, JM; Fuster, V; Michel, JB; Blanco-Colio, LM; Vazquez, J; Martin-Ventura, JL

    Complement C5 Protein as a Marker of Subclinical Atherosclerosis.

    Journal Of The American College Of Cardiology 75 1926-1941. .

    [doi:10.1016/j.jacc.2020.02.058]

Projects

  • Estancias de personal docente y/o investigador senior en centros extranjeros 2022
  • El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
  • Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
  • SPAIN CKD CAUSE (SPACKDC)
  • INVESTIGO 2022: Grup de recerca translacional vascular i renal
  • Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
  • Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
  • Acciones de Dinamización "Europa Investigación 2020"
  • Contratos Sara Borrell
  • Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
  • Ajuts destinats a contractar personal investigador novell (FI)
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.